Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC SB 204990 | 154566-12-8 | 99.8% | 389.27 | 100 MG
Supplier: Medchemexpress LLC HY16450100MG
SB 204990 is a potent and specific inhibitor of ATP citrate lyase (ACLY) enzyme. It is for research use only. SB 204990 treatment leads to a decrease in cytosolic Ac-CoA levels, which is expected to decrease acetylated and active β-catenin levels. When administered orally to rats, it is absorbed into the systemic circulation, causing a dose-related decrease in plasma cholesterol and triglyceride levels. In dogs, it also decreases plasma cholesterol and triglyceride levels, preferentially decreasing low-density lipoprotein compared with high-density lipoprotein cholesterol levels.
- Potent and specific inhibitor of ATP citrate lyase (ACLY) enzyme.
- Decreases cytosolic Ac-CoA levels.
- Reduces acetylated and active β-catenin levels.
- Decreases plasma cholesterol and triglyceride levels in rats and dogs.
- Preferentially decreases low-density lipoprotein compared with high-density lipoprotein cholesterol levels in dogs.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?